Avem Health Partners, Inc. (NYSE: FPCG) Stock Competitors & Peer Comparison
See FPCG's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for FPCG and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FPCG | $1,025.00 | +0.00% | 10.1M | 0.09 | $10,992.00 | N/A |
| HCA | $405.00 | -1.03% | 87.7B | 13.99 | $28.96 | +0.74% |
| THC | $265.05 | +0.59% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.66 | +0.85% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.79 | -0.65% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $183.99 | +1.28% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $169.65 | +0.26% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $170.79 | -0.76% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $519.84 | -0.88% | 6.8B | 24.08 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
FPCG vs HCA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while HCA trades at $405.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas HCA's P/E ratio is 13.99. In terms of profitability, FPCG's ROE is +0.00%, compared to HCA's ROE of -1.13%. Regarding short-term risk, FPCG is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
FPCG vs THC Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while THC trades at $265.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas THC's P/E ratio is 15.37. In terms of profitability, FPCG's ROE is +0.00%, compared to THC's ROE of +0.51%. Regarding short-term risk, FPCG is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
FPCG vs FMS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while FMS trades at $22.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas FMS's P/E ratio is 8.52. In terms of profitability, FPCG's ROE is +0.00%, compared to FMS's ROE of +0.07%. Regarding short-term risk, FPCG is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
FPCG vs EHC Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while EHC trades at $121.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas EHC's P/E ratio is 20.85. In terms of profitability, FPCG's ROE is +0.00%, compared to EHC's ROE of +0.25%. Regarding short-term risk, FPCG is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
FPCG vs DVA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while DVA trades at $183.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas DVA's P/E ratio is 14.37. In terms of profitability, FPCG's ROE is +0.00%, compared to DVA's ROE of -1.24%. Regarding short-term risk, FPCG is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
FPCG vs UHS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while UHS trades at $169.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas UHS's P/E ratio is 7.53. In terms of profitability, FPCG's ROE is +0.00%, compared to UHS's ROE of +0.21%. Regarding short-term risk, FPCG is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
FPCG vs ENSG Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ENSG trades at $170.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ENSG's P/E ratio is 24.75. In terms of profitability, FPCG's ROE is +0.00%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, FPCG is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
FPCG vs OSH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas OSH's P/E ratio is -17.65. In terms of profitability, FPCG's ROE is +0.00%, compared to OSH's ROE of +4.64%. Regarding short-term risk, FPCG is less volatile compared to OSH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
FPCG vs CHE Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CHE trades at $519.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CHE's P/E ratio is 24.08. In terms of profitability, FPCG's ROE is +0.00%, compared to CHE's ROE of +0.29%. Regarding short-term risk, FPCG is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
FPCG vs PACS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while PACS trades at $42.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas PACS's P/E ratio is 22.49. In terms of profitability, FPCG's ROE is +0.00%, compared to PACS's ROE of +0.27%. Regarding short-term risk, FPCG is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
FPCG vs HIMS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while HIMS trades at $27.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas HIMS's P/E ratio is -43.31. In terms of profitability, FPCG's ROE is +0.00%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, FPCG is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
FPCG vs LHCG Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas LHCG's P/E ratio is 82.83. In terms of profitability, FPCG's ROE is +0.00%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, FPCG is less volatile compared to LHCG. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
FPCG vs LFST Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while LFST trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas LFST's P/E ratio is 95.88. In terms of profitability, FPCG's ROE is +0.00%, compared to LFST's ROE of +0.03%. Regarding short-term risk, FPCG is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
FPCG vs CON Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CON trades at $34.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CON's P/E ratio is 21.68. In terms of profitability, FPCG's ROE is +0.00%, compared to CON's ROE of +0.47%. Regarding short-term risk, FPCG is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
FPCG vs OPCH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while OPCH trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas OPCH's P/E ratio is 14.08. In terms of profitability, FPCG's ROE is +0.00%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, FPCG is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
FPCG vs NHC Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while NHC trades at $218.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas NHC's P/E ratio is 27.76. In terms of profitability, FPCG's ROE is +0.00%, compared to NHC's ROE of +0.13%. Regarding short-term risk, FPCG is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
FPCG vs AMED Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AMED's P/E ratio is 39.30. In terms of profitability, FPCG's ROE is +0.00%, compared to AMED's ROE of +0.11%. Regarding short-term risk, FPCG is less volatile compared to AMED. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
FPCG vs AVAH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AVAH trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AVAH's P/E ratio is 19.97. In terms of profitability, FPCG's ROE is +0.00%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, FPCG is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
FPCG vs BKD Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while BKD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas BKD's P/E ratio is -20.30. In terms of profitability, FPCG's ROE is +0.00%, compared to BKD's ROE of +4.06%. Regarding short-term risk, FPCG is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
FPCG vs ACHC Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ACHC trades at $28.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ACHC's P/E ratio is 14.14. In terms of profitability, FPCG's ROE is +0.00%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, FPCG is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
FPCG vs GRDN Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while GRDN trades at $40.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas GRDN's P/E ratio is 35.79. In terms of profitability, FPCG's ROE is +0.00%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, FPCG is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
FPCG vs MD Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while MD trades at $27.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas MD's P/E ratio is 12.07. In terms of profitability, FPCG's ROE is +0.00%, compared to MD's ROE of +0.20%. Regarding short-term risk, FPCG is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
FPCG vs ADUS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ADUS trades at $118.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ADUS's P/E ratio is 17.78. In terms of profitability, FPCG's ROE is +0.00%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, FPCG is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
FPCG vs SEM Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas SEM's P/E ratio is 15.43. In terms of profitability, FPCG's ROE is +0.00%, compared to SEM's ROE of +0.08%. Regarding short-term risk, FPCG is less volatile compared to SEM. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
FPCG vs ASTH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ASTH trades at $38.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ASTH's P/E ratio is 46.35. In terms of profitability, FPCG's ROE is +0.00%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, FPCG is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
FPCG vs SGRY Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while SGRY trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas SGRY's P/E ratio is 36.56. In terms of profitability, FPCG's ROE is +0.00%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, FPCG is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
FPCG vs AMEH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AMEH's P/E ratio is 39.25. In terms of profitability, FPCG's ROE is +0.00%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, FPCG is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
FPCG vs SNDA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while SNDA trades at $37.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas SNDA's P/E ratio is -6.09. In terms of profitability, FPCG's ROE is +0.00%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, FPCG is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
FPCG vs ARDT Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ARDT's P/E ratio is 8.79. In terms of profitability, FPCG's ROE is +0.00%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, FPCG is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
FPCG vs HCSG Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while HCSG trades at $21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas HCSG's P/E ratio is 17.46. In terms of profitability, FPCG's ROE is +0.00%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, FPCG is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
FPCG vs AGL Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AGL trades at $88.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AGL's P/E ratio is -5.72. In terms of profitability, FPCG's ROE is +0.00%, compared to AGL's ROE of -1.19%. Regarding short-term risk, FPCG is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
FPCG vs INNV Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while INNV trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas INNV's P/E ratio is -119.44. In terms of profitability, FPCG's ROE is +0.00%, compared to INNV's ROE of -0.09%. Regarding short-term risk, FPCG is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
FPCG vs NUTX Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while NUTX trades at $193.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas NUTX's P/E ratio is 7.65. In terms of profitability, FPCG's ROE is +0.00%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, FPCG is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
FPCG vs PNTG Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while PNTG trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas PNTG's P/E ratio is 28.79. In terms of profitability, FPCG's ROE is +0.00%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, FPCG is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
FPCG vs AMN Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AMN trades at $33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AMN's P/E ratio is 11.23. In terms of profitability, FPCG's ROE is +0.00%, compared to AMN's ROE of +0.15%. Regarding short-term risk, FPCG is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
FPCG vs BKDT Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas BKDT's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, FPCG is similarly volatile compared to BKDT. This indicates similar risk in terms of short-term price fluctuations for FPCG.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
FPCG vs USPH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while USPH trades at $79.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas USPH's P/E ratio is 31.25. In terms of profitability, FPCG's ROE is +0.00%, compared to USPH's ROE of -0.01%. Regarding short-term risk, FPCG is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
FPCG vs TALK Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TALK's P/E ratio is 774.34. In terms of profitability, FPCG's ROE is +0.00%, compared to TALK's ROE of +0.00%. Regarding short-term risk, FPCG is less volatile compared to TALK. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
FPCG vs GMRS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, GMRS has a market cap of 728.1M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while GMRS trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas GMRS's P/E ratio is 5.99. In terms of profitability, FPCG's ROE is +0.00%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, FPCG is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
FPCG vs EHAB Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas EHAB's P/E ratio is -197.14. In terms of profitability, FPCG's ROE is +0.00%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, FPCG is less volatile compared to EHAB. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
FPCG vs STLN Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while STLN trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas STLN's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to STLN's ROE of +2.10%. Regarding short-term risk, FPCG is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
FPCG vs TOI Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TOI's P/E ratio is -14.25. In terms of profitability, FPCG's ROE is +0.00%, compared to TOI's ROE of +2.10%. Regarding short-term risk, FPCG is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
FPCG vs SRTA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while SRTA trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas SRTA's P/E ratio is -25.08. In terms of profitability, FPCG's ROE is +0.00%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, FPCG is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
FPCG vs MCTA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas MCTA's P/E ratio is 419.36. In terms of profitability, FPCG's ROE is +0.00%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, FPCG is similarly volatile compared to MCTA. This indicates similar risk in terms of short-term price fluctuations for FPCG.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
FPCG vs CYH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CYH has a market cap of 406.8M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CYH trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CYH's P/E ratio is 3.95. In terms of profitability, FPCG's ROE is +0.00%, compared to CYH's ROE of +0.21%. Regarding short-term risk, FPCG is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
FPCG vs AUNA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AUNA has a market cap of 391.6M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AUNA trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AUNA's P/E ratio is 4.77. In terms of profitability, FPCG's ROE is +0.00%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, FPCG is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
FPCG vs VMD Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while VMD trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas VMD's P/E ratio is 25.22. In terms of profitability, FPCG's ROE is +0.00%, compared to VMD's ROE of +0.10%. Regarding short-term risk, FPCG is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
FPCG vs CSU Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CSU's P/E ratio is 0.67. In terms of profitability, FPCG's ROE is +0.00%, compared to CSU's ROE of -0.33%. Regarding short-term risk, FPCG is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
FPCG vs AIRS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AIRS's P/E ratio is -93.17. In terms of profitability, FPCG's ROE is +0.00%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, FPCG is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
FPCG vs JYNT Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while JYNT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas JYNT's P/E ratio is 83.20. In terms of profitability, FPCG's ROE is +0.00%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, FPCG is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
FPCG vs FVE Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas FVE's P/E ratio is -5.64. In terms of profitability, FPCG's ROE is +0.00%, compared to FVE's ROE of -0.15%. Regarding short-term risk, FPCG is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
FPCG vs KDLYW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas KDLYW's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, FPCG is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
FPCG vs PARK Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while PARK trades at $20.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas PARK's P/E ratio is 27.61. In terms of profitability, FPCG's ROE is +0.00%, compared to PARK's ROE of -0.18%. Regarding short-term risk, FPCG is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
FPCG vs BTMD Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while BTMD trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas BTMD's P/E ratio is 14.05. In terms of profitability, FPCG's ROE is +0.00%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, FPCG is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
FPCG vs ALR Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ALR's P/E ratio is -1.11. In terms of profitability, FPCG's ROE is +0.00%, compared to ALR's ROE of -0.15%. Regarding short-term risk, FPCG is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
FPCG vs DCGO Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while DCGO trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas DCGO's P/E ratio is -0.22. In terms of profitability, FPCG's ROE is +0.00%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, FPCG is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
FPCG vs CCEL Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CCEL trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CCEL's P/E ratio is -14.27. In terms of profitability, FPCG's ROE is +0.00%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, FPCG is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
FPCG vs IMAC Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas IMAC's P/E ratio is -2.27. In terms of profitability, FPCG's ROE is +0.00%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, FPCG is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
FPCG vs PIII Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while PIII trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas PIII's P/E ratio is -0.28. In terms of profitability, FPCG's ROE is +0.00%, compared to PIII's ROE of +1.61%. Regarding short-term risk, FPCG is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
FPCG vs EUDA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, EUDA has a market cap of 25.4M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while EUDA trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas EUDA's P/E ratio is -25.66. In terms of profitability, FPCG's ROE is +0.00%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, FPCG is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
FPCG vs PIIIW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas PIIIW's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, FPCG is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
FPCG vs CANO-WT Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, FPCG is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
FPCG vs AIH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AIH's P/E ratio is -2.78. In terms of profitability, FPCG's ROE is +0.00%, compared to AIH's ROE of +1.16%. Regarding short-term risk, FPCG is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
FPCG vs CANO Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CANO's P/E ratio is -0.01. In terms of profitability, FPCG's ROE is +0.00%, compared to CANO's ROE of -1.49%. Regarding short-term risk, FPCG is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CANO's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
FPCG vs FTRP Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas FTRP's P/E ratio is -1.22. In terms of profitability, FPCG's ROE is +0.00%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, FPCG is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
FPCG vs AMS Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AMS's P/E ratio is -5.66. In terms of profitability, FPCG's ROE is +0.00%, compared to AMS's ROE of -0.07%. Regarding short-term risk, FPCG is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
FPCG vs BMGL Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while BMGL trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas BMGL's P/E ratio is -0.91. In terms of profitability, FPCG's ROE is +0.00%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, FPCG is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
FPCG vs AIDX Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AIDX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AIDX's P/E ratio is -1.12. In terms of profitability, FPCG's ROE is +0.00%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, FPCG is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
FPCG vs MODV Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas MODV's P/E ratio is -0.06. In terms of profitability, FPCG's ROE is +0.00%, compared to MODV's ROE of +1.36%. Regarding short-term risk, FPCG is similarly volatile compared to MODV. This indicates similar risk in terms of short-term price fluctuations for FPCG.Check MODV's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
FPCG vs STLNW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, STLNW has a market cap of 5.5M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas STLNW's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, FPCG is similarly volatile compared to STLNW. This indicates similar risk in terms of short-term price fluctuations for FPCG.Check STLNW's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
FPCG vs GBNH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas GBNH's P/E ratio is -0.06. In terms of profitability, FPCG's ROE is +0.00%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, FPCG is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
FPCG vs RHE Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas RHE's P/E ratio is -1.79. In terms of profitability, FPCG's ROE is +0.00%, compared to RHE's ROE of -1.31%. Regarding short-term risk, FPCG is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
FPCG vs RHE-PA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, FPCG's ROE is +0.00%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, FPCG is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
FPCG vs TOIIW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, FPCG's ROE is +0.00%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, FPCG is similarly volatile compared to TOIIW. This indicates similar risk in terms of short-term price fluctuations for FPCG.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
FPCG vs IMACW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas IMACW's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, FPCG is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
FPCG vs EDVA Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas EDVA's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to EDVA's ROE of N/A. Regarding short-term risk, FPCG is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
FPCG vs EUDAW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, FPCG's ROE is +0.00%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, FPCG is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
FPCG vs CCM Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while CCM trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas CCM's P/E ratio is -0.30. In terms of profitability, FPCG's ROE is +0.00%, compared to CCM's ROE of +0.06%. Regarding short-term risk, FPCG is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
FPCG vs NIVF Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while NIVF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas NIVF's P/E ratio is 0.56. In terms of profitability, FPCG's ROE is +0.00%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, FPCG is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
FPCG vs NIVFW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, NIVFW has a market cap of 45.5K. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, FPCG's ROE is +0.00%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, FPCG is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
FPCG vs MNDR Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while MNDR trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas MNDR's P/E ratio is -0.04. In terms of profitability, FPCG's ROE is +0.00%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, FPCG is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
FPCG vs TALKW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TALKW's P/E ratio is 0.00. In terms of profitability, FPCG's ROE is +0.00%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, FPCG is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check TALKW's competition here
DocGo Inc. (NASDAQ: DCGOW)
FPCG vs DCGOW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas DCGOW's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, FPCG is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check DCGOW's competition here
New Frontier Health Corporation (NYSE: NFH)
FPCG vs NFH Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, NFH has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas NFH's P/E ratio is -19.75. In terms of profitability, FPCG's ROE is +0.00%, compared to NFH's ROE of -0.06%. Regarding short-term risk, FPCG is less volatile compared to NFH. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
FPCG vs SLHG Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas SLHG's P/E ratio is -1.48. In terms of profitability, FPCG's ROE is +0.00%, compared to SLHG's ROE of N/A. Regarding short-term risk, FPCG is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check SLHG's competition here
Kindred Healthcare, Inc. (NYSE: KND)
FPCG vs KND Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, KND has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas KND's P/E ratio is -1.14. In terms of profitability, FPCG's ROE is +0.00%, compared to KND's ROE of -0.53%. Regarding short-term risk, FPCG is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check KND's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
FPCG vs TVTY Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TVTY's P/E ratio is 19.06. In terms of profitability, FPCG's ROE is +0.00%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, FPCG is less volatile compared to TVTY. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check TVTY's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
FPCG vs ATIP-WT Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, FPCG is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
FPCG vs HNGR Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas HNGR's P/E ratio is 19.71. In terms of profitability, FPCG's ROE is +0.00%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, FPCG is less volatile compared to HNGR. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
FPCG vs SLHGP Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, FPCG's ROE is +0.00%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, FPCG is similarly volatile compared to SLHGP. This indicates similar risk in terms of short-term price fluctuations for FPCG.Check SLHGP's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
FPCG vs TLMDW Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TLMDW's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, FPCG is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check TLMDW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
FPCG vs DVCR Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas DVCR's P/E ratio is 28.34. In terms of profitability, FPCG's ROE is +0.00%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, FPCG is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
FPCG vs AFAM Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas AFAM's P/E ratio is N/A. In terms of profitability, FPCG's ROE is +0.00%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, FPCG is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
FPCG vs TLMD Comparison September 2026
Avem Health Partners, Inc. (NYSE: FPCG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPCG stands at 10.1M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, FPCG is priced at $1,025.00 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPCG currently has a P/E ratio of 0.09, whereas TLMD's P/E ratio is -1.60. In terms of profitability, FPCG's ROE is +0.00%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, FPCG is less volatile compared to TLMD. This indicates lower risk in terms of short-term price fluctuations for FPCG.Check TLMD's competition here